Filer Snapshot

Lars Boesgaard

CIK 0001403893. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

15

Latest filing

03 Mar 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for PDSB. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 03 Mar 2026 for CIK 0001403893.

View source filing
Business address
C/O Roka Bioscience, Inc., 20 Independence Boulevard, Warren, NJ, 07059

Filer intelligence

What SEC filings say about Lars Boesgaard

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for PDSB.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

PDSB

12 Jan 2026 ยท Chief Financial Officer

Latest update

What changed recently for Lars Boesgaard

Ownership report updated

Latest ownership report period: 12 Jan 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

03 Mar 2026

Page type

Ownership filings

Latest period

12 Jan 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 03 Mar 2026.

SEC filing record

CIK 0001403893 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
15
First seen
25 Jun 2007
Latest filing
03 Mar 2026
Entity
Individual

Observed form types

4 3

Latest Filings

Showing the latest 10 of 10 SEC filings for Lars Boesgaard.

4 File 001-37568

FORM 4

Filing date
03 Mar 2026
Reporting date
12 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-37568

FORM 4

Filing date
25 Jul 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-37568

4 filing

Filing date
04 Dec 2023
Reporting date
04 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-37568

3 filing

Filing date
04 Dec 2023
Reporting date
04 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36538

FORM 4

Filing date
28 Mar 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36538

FORM 4

Filing date
10 Nov 2016
Reporting date
10 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36538

FORM 4

Filing date
23 Sep 2016
Reporting date
21 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36538

FORM 4

Filing date
05 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36538

FORM 4

Filing date
07 Dec 2015
Reporting date
06 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36538

FORM 3

Filing date
18 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .